Skip to content

F4/80 Recombinant Antibody [PSH01-87] - Mouse IgG1 (Chimeric) - BSA and Azide free

Usd: 649

Specification

Bulk Order Quote | Customization Request

Catalog# HA610356

F4/80 Recombinant Antibody [PSH01-87] - Mouse IgG1 (Chimeric) - BSA and Azide free

Application

  • WB

  • IHC-P

Reactivity

  • Mouse

With BSA and Azide
Conjugation

  • unconjugated

Overview

Product Name

F4/80 Recombinant Antibody [PSH01-87] - Mouse IgG1 (Chimeric) - BSA and Azide free

Antibody Type

Recombinant Chimeric Antibody

Immunogen

Recombinant protein within mouse F4/80 aa 1-650 / 931.

Species Reactivity

Mouse

Validated Applications

WB, IHC-P

Target Molecular Weight

Predicted band size: 102 kDa

Positive Control

RAW264.7 cell lysate, Mouse spleen tissue lysate, mouse liver tissue, mouse lung tissue.

Conjugation

unconjugated

Clone Number

PSH01-87

Product Features

Form

Liquid

Concentration

1mg/ml

Storage Instructions

Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles.

Storage Buffer

1*PBS (pH7.4).

Isotype

IgG

Purification Method

Protein A affinity purified.

Application Dilution

  • WB

  • 1:5,000

  • IHC-P

  • 1:2,000-1:5,000

Target

Function

EGF-like module-containing mucin-like hormone receptor-like 1 also known as F4/80 is a protein encoded by the ADGRE1 gene. EMR1 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain. EMR1 expression in human is restricted to eosinophils and is a specific marker for these cells. The murine homolog of EMR1, F4/80, is a well-known and widely used marker of murine macrophage populations. The N-terminal fragment (NTF) of EMR1 contains 4-6 Epidermal Growth Factor-like (EGF-like) domains in human and 4-7 EGF-like domains in the mouse. Utilizing F4/80 knockout mice, Lin et al. showed that F4/80 is not necessary for the development of tissue macrophages but is required for the induction of efferent CD8+ regulatory T cells needed for peripheral tolerance.

Background References

1. Shin AE et al. F4/80(+)Ly6C(high) Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis. Gastroenterology. 2023 Apr

2. Deng R et al. Periosteal CD68(+) F4/80(+) Macrophages Are Mechanosensitive for Cortical Bone Formation by Secretion and Activation of TGF-beta1. Adv Sci (Weinh). 2022 Jan

Subcellular Location

Cell membrane.

UNIPROT

SwissProt: Q61549 Mouse

Synonyms

ADGRE1 antibody

Adhesion G protein coupled receptor E1 antibody

Adhesion G protein-coupled receptor E1 antibody

AGRE1_HUMAN antibody

Cell surface glycoprotein EMR1 antibody

Cell surface glycoprotein F4/80 antibody

DD7A5 7 antibody

Egf like module containing mucin like hormone receptor like 1 antibody

Egf like module containing mucin like hormone receptor like sequence 1 antibody

EGF like module receptor 1 antibody

Expand

Images

  • <span style="font-weight: bold;">☑ Relative expression (RE)</span><br /><br />Western blot analysis of F4/80 on different lysates with Mouse anti-F4/80 antibody (<a href="/products/HA610356" style="font-weight: bold;text-decoration: underline;">HA610356</a>) at 1/5,000 dilution.<br /><br />Lane 1: RAW264.7 cell lysate (no heat) (10 µg/Lane)<br />Lane 2: L-929 cell lysate (negative) (10 µg/Lane)<br />Lane 3: Mouse spleen tissue lysate (no heat) (10 µg/Lane)<br /><br />Notice: no heat means the lysate is not boiled.<br /><br />Predicted band size: 102 kDa<br />Observed band size: 150 kDa<br /><br />Exposure time: 1 minute 2 seconds; ECL: K1801;<br />4-20% SDS-PAGE gel.<br /><br />Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (<a href="/products/HA610356" style="font-weight: bold;text-decoration: underline;">HA610356</a>) at 1/5,000 dilution was used in primary antibody dilution (<a href="/products/K1803" style="font-weight: bold;text-decoration: underline;">K1803</a>) at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (<a href="/products/HA1006" style="font-weight: bold;text-decoration: underline;">HA1006</a>) at 1/50,000 dilution was used for 1 hour at room temperature.

    ☑ Relative expression (RE)

    Western blot analysis of F4/80 on different lysates with Mouse anti-F4/80 antibody (HA610356) at 1/5,000 dilution.

    Lane 1: RAW264.7 cell lysate (no heat) (10 µg/Lane)
    Lane 2: L-929 cell lysate (negative) (10 µg/Lane)
    Lane 3: Mouse spleen tissue lysate (no heat) (10 µg/Lane)

    Notice: no heat means the lysate is not boiled.

    Predicted band size: 102 kDa
    Observed band size: 150 kDa

    Exposure time: 1 minute 2 seconds; ECL: K1801;
    4-20% SDS-PAGE gel.

    Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA610356) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature.

  • Immunohistochemical analysis of paraffin-embedded mouse liver tissue with Mouse anti-F4/80 antibody (<a href="/products/HA610356" style="font-weight: bold;text-decoration: underline;">HA610356</a>) at 1/5,000 dilution.<br /><br />The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH<sub>2</sub>O and PBS, and then probed with the primary antibody (<a href="/products/HA610356" style="font-weight: bold;text-decoration: underline;">HA610356</a>) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.

    Immunohistochemical analysis of paraffin-embedded mouse liver tissue with Mouse anti-F4/80 antibody (HA610356) at 1/5,000 dilution.

    The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA610356) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.

  • Immunohistochemical analysis of paraffin-embedded mouse lung tissue with Mouse anti-F4/80 antibody (<a href="/products/HA610356" style="font-weight: bold;text-decoration: underline;">HA610356</a>) at 1/2,000 dilution.<br /><br />The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH<sub>2</sub>O and PBS, and then probed with the primary antibody (<a href="/products/HA610356" style="font-weight: bold;text-decoration: underline;">HA610356</a>) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.

    Immunohistochemical analysis of paraffin-embedded mouse lung tissue with Mouse anti-F4/80 antibody (HA610356) at 1/2,000 dilution.

    The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA610356) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"